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urgeons and
nterventional Cardiologists in
Collaborative Environment*
ntonio Colombo, MD, FACC, Azeem Latib, MD
ilan, Italy
he concept of an interventional cardiologist coming to
elp or correct a surgical problem during or shortly after
oronary artery bypass surgery (CABG) was first introduced
n 1998 by Reifart et al. (1). In their original report, Reifart
t al. (1) performed emergency angiography, and when
easible, percutaneous coronary intervention (PCI) in 55
atients with clinical ischemia within 24 h of CABG. With
he knowledge that many patients may experience asymp-
omatic failure of a recently implanted graft or malfunction-
ng of a left internal mammary artery (LIMA) graft, it is
ow time to go 1 step further.
See page 232
In the interest of our patients, it does not seem acceptable
o see that over one-fourth of vein grafts and 8% of LIMA
rafts may fail within 1 year of implantation (2). The
nterventional cardiologist should not unconstructively crit-
cize CABG by stressing early graft failure to compensate
or restenosis or stent thrombosis. When we put the patient
t the center of our work, we take into account the problems
nd try to solve them. The Vanderbilt Heart and Vascular
nstitute reports in this issue of the Journal the results of a
onstructive collaboration (3).
The team (surgeons and/or interventional cardiologists)
erformed an angiogram in a hybrid operating room in 366
atients who underwent CABG before chest closure. The
haracteristics of this population were not benign, with 39%
f the patients being diabetics, more than one-half present-
ng with unstable angina, and one-fourth with significant
eft main vessel narrowing. In the event that a defect in a
ein graft or the LIMA graft was detected, the operators
roceeded immediately to its correction with a percutaneous
pproach or with surgical revision. Among these 366 pa-
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.S
From San Raffaele Scientific Institute and EMO-GVM Centro Cuore Columbus,
ilan, Italy.ients, 67 (18%) underwent a planned PCI procedure as
ell. Antiplatelet medications were given with a loading
ose of 300 mg clopidogrel immediately before surgery for
he patients who underwent elective PCI (hybrid proce-
ures) or by nasogastric tube at the time that the decision
or unplanned open-chest PCI was made. Aspirin was given
o all patients immediately after CABG, and heparin was
eversed with protamine in all patients.
Overall, the operators found angiographic defects in 89
atients (i.e., 12% of grafts) described in Table 4 (3), and
his provides interesting insights into the mechanisms of
arly graft failure. Adjustments had to be performed in 22
rafts and in 25 LIMA grafts. In Table 4 (3), the investi-
ators describe in detail the specific PCI or surgical adjust-
ents that were made. However, a question remains regard-
ng whether correcting these angiographic defects will
mprove graft patency. We look forward to the follow-up of
hese grafts, which has been planned at 12 months with
ultislice computed tomography. Including the patients
ho underwent a planned intervention, the 112 patients
reated with additional PCI received 1.8 stents on average,
nd 84% of them were drug-eluting stents. The operative
ortality was 2.6% in the hybrid group and 1.5% in the
tandard CABG group. A reoperation to control bleeding
as required in 3% of patients, and the median need for
ransfusions was 1 unit per patient, with a similar number of
eoperations and transfusions in the patients who received
lopidogrel and the ones without. Creatine-kinase MB and
roponin I levels were higher in patients who underwent
dditional PCI. There was only 1 case of stent thrombosis.
n interesting remark the investigators make is the fact that
any of the findings detected on angiography performed
fter CABG may help highlight to the surgeon possible
echnical issues that could be utilized to prevent future
naccuracies. The fact that the graft defect rate decreased
rom 15% to 11% during the study may be a small sign in
he right direction. An issue that remains open to debate is
he fact that sometimes some defects seen immediately after
urgery such as haziness or kinking may correct spontane-
usly with time, making the need for an intraoperative PCI
useless action. Only mature judgment and profound
xperience will likely allow the surgeon to tell up front
hich are the malignant or the benign defects.
A separate evaluation and discussion should be devoted to
he planned hybrid procedures. In particular, what are the
dvantages of a planned hybrid procedure for the patient? In
he present study, a hybrid CABG/PCI was associated with
ess aortic cross-clamp and cardiopulmonary bypass time, as
ell as a greater use of off-pump CABG. However, this was
t an expense of greater myocardial injury as detected by
ardiac enzymes and larger doses of contrast in the periop-
rative period. In addition, there was no significant differ-
nce in operative mortality between patients having hybrid
urgery compared with those having a standard CABG.
imilarly, other studies have shown that that hybrid
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January 20, 2009:242–3 Hybrid Coronary RevascularizationABG/PCI results in shorter hospital stays and intubation
imes without an increased risk of bleeding and without
lear evidence of benefit on hard clinical end points (4–6).
he field of hybrid coronary revascularization, except in
ome very selected cases, is open to debate because most
xperienced interventionists believe that the only restriction
o achieving adequate percutaneous revascularization is a
otal occlusion of the left anterior descending artery, which
annot be opened. The best way to avoid an unproductive
ebate is for the interventional cardiologist and the cardiac
urgeon to sit together in front of the angiogram, keeping in
ind the clinical scenario of the patient to be treated, and
penly discuss the issues around the best revascularization
trategy that can be offered. The final decision should take
nto consideration the important clinical and social aspects
pecific to that patient. It is interesting to point out that this
pproach, which has been utilized in the SYNTAX (Syn-
rgy between Percutaneous Coronary Intervention with
AXUS and Cardiac Surgery) trial, has created a surgical
egistry of 1,077 patients. These patients were judged by an
nterventional cardiologist to be unsuitable for optimal
evascularization with PCI, whereas they were considered
ery appropriate for surgical revascularization. We wonder
hether the already excellent results of the surgical registry
ould have been further improved with the hybrid option.
n the other hand, there is the group randomized to PCI or
ABG. A more advanced analysis of these patients will
ighlight subgroups of patients with very complex anatomy
equiring multiple stents, sometimes more than 7 stents.
gain we need to ask ourselves whether the results could
ave been improved with the option of a hybrid procedure
eing offered to some patients randomized to PCI. The
bjective of this Editorial Comment is not to examine and
iscuss the large field of hybrid surgery, and therefore we
ill not extend out comments. An important practical
uestion that should not be dismissed is: Does hybrid
urgery need to be performed in 1 setting, or can we perform
he PCI in a second session? As pointed out by the
nvestigators, this second strategy allows verification of
orrect performance of the LIMA graft with angiography.
espite some good rationales, we cannot dismiss the fact
hat neither of the 2 approaches, that is, true hybrid
evascularization or deferred PCI, has encountered much
avor with cardiologists and patients. As an example, a
eport from Hamburg, Germany, reported only 57 patients
ver a 4-year period undergoing hybrid revascularization
onsisting of LIMA implantation to the left anterior de-
cending artery with PCI on the other vessels (6).
K
pThis is the practical final message to take home from this
mportant work. 1) Despite the interesting findings reported
n the study of Zhao et al. (3), we are not convinced that all
ABG should be checked with immediate angiography.
here are no data at present to suggest that this approach
ill improve graft patency. 2) The fact that the option of a
ontrol angiogram followed by a surgical PCI procedure can
e effectively and safely performed, as shown in this study,
ives the surgeon and interventional cardiologist a further
ossibility of improving the final result in specific cases.
As seen very frequently in medicine, the strategy for
owering the number needed to treat (angiography for all
ABG) lies in the skill and willingness of the surgeon to
stablish in which specific cases the complexity or some
echnical problems may have prevented the performance of
procedure as exactly and smoothly as planned. Knowing
he result, even if not as expected, is always more effective
han ignoring a problem. As shown in this article, the
orrection always comes after having seen the defect.
eprint requests and correspondence: Dr. Antonio Colombo,
MO Centro Cuore Columbus, Via Buonarroti 48, 20145 Milan,
taly. E-mail: info@emocolumbus.it.
EFERENCES
. Reifart N, Storger H, Schwarz F, Besser R, Iversen S. [From surgical to
interventional standby?]. Z Kardiol 1998;87 Suppl 3:8–11, discussion
14–5.
. Alexander JH, Hafley G, Harrington RA, et al. Efficacy and safety of
edifoligide, an E2F transcription factor decoy, for prevention of vein
graft failure following coronary artery bypass graft surgery: PREVENT
IV: a randomized controlled trial. JAMA 2005;294:2446–54.
. Zhao DX, Leacche M, Balaguer JM, et al., the Writing Group on
behalf of the Cardiac Surgery, Cardiac Anesthesiology, and Interven-
tional Cardiology Groups at the Vanderbilt Heart and Vascular Insti-
tute. Routine intraoperative completion angiography after coronary
artery bypass grafting and 1-stop hybrid revascularization: results from
a fully integrated hybrid catheterization laboratory/operating room.
J Am Coll Cardiol 2009;53:232–41.
. Kon ZN, Brown EN, Tran R, et al. Simultaneous hybrid coronary
revascularization reduces postoperative morbidity compared with results
from conventional off-pump coronary artery bypass. J Thorac Cardio-
vasc Surg 2008;135:367–75.
. Reicher B, Poston RS, Mehra MR, et al. Simultaneous “hybrid”
percutaneous coronary intervention and minimally invasive surgical
bypass grafting: feasibility, safety, and clinical outcomes. Am Heart J
2008;155:661–7.
. Riess FC, Bader R, Kremer P, et al. Coronary hybrid revascularization
from January 1997 to January 2001: a clinical follow-up. Ann Thorac
Surg 2002;73:1849–55.ey Words: hybrid coronary revascularization y coronary angiography y
ercutaneous coronary intervention y coronary artery bypass surgery.
